Biotech M&A Rebound Bodes Well for Venture Investors

Regulatory scrutiny of acquisitions could slow momentum. #press

https://www.wsj.com/articles/biotech-m-a-rebound-bodes-well-for-venture-investors-8dbc0e86?utm_source=press.coop